A Phase 2b Study of Modified Vaccinia Virus to Treat Advanced Liver Cancer (TRAVERSE)

Sponsor and Collaborators     
Jennerex Biotherapeutics

Contact
Caro Unger         
patientinquiry@jennerex.com

Investigator
David Kirn, MD


Continue Reading

ClinicalTrials.gov Identifier
NCT01387555